3.4.21.48	3,4-dichloroisocoumarin	-	1040	
3.4.21.48	Ag+	-	75	
3.4.21.48	antipain	-	520	
3.4.21.48	antipain	0.001 mM	520	
3.4.21.48	Aprotinin	i.e. trasylol, weak	405	
3.4.21.48	chymostatin	-	511	
3.4.21.48	chymostatin	0.001 mM	511	
3.4.21.48	Cu2+	-	19	
3.4.21.48	DFP	-	923	
3.4.21.48	Hg2+	HgCl2	33	
3.4.21.48	Hg2+	fully reversed by Cys	33	
3.4.21.48	iodoacetamide	-	67	
3.4.21.48	iodoacetate	-	93	
3.4.21.48	leupeptin	-	217	
3.4.21.48	additional information	presence of endogenous inhibitor, inhibitory activity is lost after 20 h at 25°C	2	
3.4.21.48	additional information	proteinase B is difficult to detect unless the firmly bound inhibitor is previously inactivated. Procedure to unmask proteinase B activity by trypsin treatment	2	
3.4.21.48	additional information	inhibition by turkey egg white fraction II-T	2	
3.4.21.48	p-hydroxymercuribenzoate	-	98	
3.4.21.48	PCMB	-	78	
3.4.21.48	PCMB	inhibition is partly reversed by Cys	78	
3.4.21.48	pepstatin	-	396	
3.4.21.48	PMSF	-	248	
3.4.21.48	proteinase B inhibitor	proteinase B inhibitor 1 and 2 are polypeptides of 8500 Da	47473	
3.4.21.48	proteinase B inhibitor	purification	47473	
3.4.21.48	Trypsin inhibitor	inhibitor isolated from potato tuber	2103	
3.4.21.48	Trypsin inhibitor	weak	2103	
3.4.21.48	Trypsin inhibitor	-	2103